Skip to main content Accessibility help
×
Home

fMRI detection of early neural dysfunction in preclinical Huntington's disease

  • JANICE L. ZIMBELMAN (a1) (a2), JANE S. PAULSEN (a3), ANIA MIKOS (a3), NORMAN C. REYNOLDS (a1), RAYMOND G. HOFFMANN (a4) and STEPHEN M. RAO (a1) (a2)...

Abstract

Neuropsychological and neuroimaging changes have been observed in individuals with the Huntington's disease (HD) gene expansion prior to the onset of manifest HD. This cross-sectional fMRI study of preclinical HD (pre-HD) individuals was conducted to determine if functional brain changes precede deficits in behavioral performance and striatal atrophy. Twenty-six pre-HD and 13 demographically matched healthy participants performed a time reproduction task while undergoing fMRI scanning. Pre-HD participants were divided into two groups (n = 13 each): FAR (>12 years to estimated onset [YEO] of manifest HD) and CLOSE (<12 YEO). The CLOSE group demonstrated behavioral deficits, striatal atrophy, and reduced neural activation in the left putamen, SMA, left anterior insula and right inferior frontal gyrus. The FAR group showed reduced neural activation in the right anterior cingulate and right anterior insula. The FAR group also demonstrated increased neural activation in the left sensorimotor, left medial frontal gyrus, left precentral gyrus, bilateral superior temporal gyri and right cerebellum. The fMRI changes in the FAR group occurred in the relative absence of striatal atrophy and behavioral performance deficits. These results suggest that fMRI is sensitive to neural dysfunction occurring more than 12 years prior to the estimated onset of manifest HD. (JINS, 2007, 13, 758–769.)

Copyright

Corresponding author

Correspondence and reprint requests to: Stephen M. Rao, Ph.D., Cleveland Clinic Foundation/U10, 9500 Euclid Avenue, Cleveland, OH 44195. E-mail: raos2@ccf.org

References

Hide All

REFERENCES

Ashburner, J. & Friston, K.J. (2000). Voxel-based morphometry: The methods. Neuroimage, 11, 805821.
Ashburner, J. & Friston, K.J. (2005). Unified segmentation. Neuroimage, 26, 839851.
Aylward, E.H., Brandt, J., Codori, A.M., Mangus, R.S., Barta, P.E., & Harris, G.J. (1994). Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology, 44, 823828.
Aylward, E.H., Codori, A.M., Barta, P.E., Pearlson, G.D., Harris, G.J., & Brandt, J. (1996). Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. Archives of Neurology, 53, 12931296.
Aylward, E.H., Codori, A.M., Rosenblatt, A., Sherr, M., Brandt, J., Stine, O.C., Barta, P.E., Pearlson, G.D., & Ross, C.A. (2000). Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Movement Disorders, 15, 552560.
Aylward, E.H., Sparks, B.F., Field, K.M., Yallapragada, V., Shpritz, B.D., Rosenblatt, A., Brandt, J., Gourley, L.M., Liang, K., Zhou, H., Margolis, R.L., & Ross, C.A. (2004). Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology, 63, 6672.
Bartenstein, P., Weindl, A., Spiegel, S., Boecker, H., Wenzel, R., Ceballos-Baumann, A.O., Minoshima, S., & Conrad, B. (1997). Central motor processing in Huntington's disease. A PET study. Brain, 120 (Pt. 9), 15531567.
Bassett, S.S., Yousem, D.M., Cristinzio, C., Kusevic, I., Yassa, M.A., Caffo, B.S., & Zeger, S.L. (2006). Familial risk for Alzheimer's disease alters fMRI activation patterns. Brain, 129, 12291239.
Bookheimer, S.Y., Strojwas, M.H., Cohen, M.S., Saunders, A.M., Pericak-Vance, M.A., Mazziotta, J.C., & Small, G.W. (2000). Patterns of brain activation in people at risk for Alzheimer's disease. New England Journal of Medicine, 343, 450456.
Brinkman, R.R., Mezei, M.M., Theilmann, J., Almqvist, E., & Hayden, M.R. (1997). The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. American Journal of Human Genetics, 60, 12021210.
Campodonico, J.R., Codori, A.M., & Brandt, J. (1996). Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation. Journal of Neurology, Neurosurgery, and Psychiatry, 61, 621624.
Celone, K.A., Calhoun, V.D., Dickerson, B.C., Atri, A., Chua, E.F., Miller, S.L., DePeau, K., Rentz, D.M., Selkoe, D.J., Blacker, D., Albert, M.S., & Sperling, R.A. (2006). Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: An independent component analysis. Journal of Neuroscience, 26, 1022210231.
Cox, R.W. (1996). AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages. Computers and Biomedical Research, 29, 162173.
Cox, R.W. & Hyde, J.S. (1997). Software tools for analysis and visualization of fMRI data. NMR in Biomedicine, 10, 171178.
Davatzikos, C. (2004). Why voxel-based morphometric analysis should be used with great caution when characterizing group differences. Neuroimage, 23, 1720.
DeKosky, S.T., Ikonomovic, M.D., Styren, S.D., Beckett, L., Wisniewski, S., Bennett, D.A., Cochran, E.J., Kordower, J.H., & Mufson, E.J. (2002). Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Annals of Neurology, 51, 145155.
Elsinger, C.L., Rao, S.M., Zimbelman, J.L., Reynolds, N.C., Blindauer, K.A., & Hoffmann, R.G. (2003). Neural basis for impaired time reproduction in Parkinson's disease: An fMRI study. Journal of the International Neuropsychological Society, 9, 10881098.
Feigin, A., Leenders, K.L., Moeller, J.R., Missimer, J., Kuenig, G., Spetsieris, P., Antonini, A., & Eidelberg, D. (2001). Metabolic network abnormalities in early Huntington's disease: An [(18)F]FDG PET study. Journal of Nuclear Medicine, 42, 15911595.
Gauthier, L.R., Charrin, B.C., Borrell-Pages, M., Dompierre, J.P., Rangone, H., Cordelieres, F.P., De, M.J., MacDonald, M.E., Lessmann, V., Humbert, S., & Saudou, F. (2004). Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell, 118, 127138.
Good, C.D., Johnsrude, I.S., Ashburner, J., Henson, R.N., Friston, K.J., & Frackowiak, R.S. (2001). A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage, 14, 2136.
Gu, X., Li, C., Wei, W., Lo, V., Gong, S., Li, S.H., Iwasato, T., Itohara, S., Li, X.J., Mody, I., Heintz, N., & Yang, X.W. (2005). Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron, 46, 433444.
Harrington, D.L., Haaland, K.Y., & Hermanowicz, N. (1998). Temporal processing in the basal ganglia. Neuropsychology, 12, 312.
Harris, G.J., Codori, A.M., Lewis, R.F., Schmidt, E., Bedi, A., & Brandt, J. (1999). Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. Brain, 122 (Pt 9), 16671678.
Hoshi, E., Tremblay, L., Feger, J., Carras, P.L., & Strick, P.L. (2005). The cerebellum communicates with the basal ganglia. National Neuroscience, 8, 14911493.
Huntington Study Group, (1996). Unified Huntington's disease Rating Scale: Reliability and consistency. Huntington Study Group. Movement Disorders, 11, 136142.
Ivry, R.B. & Keele, S.W. (1989). Timing functions of the cerebellum. Journal of Cognitive Neuroscience, 1, 134150.
Kirkwood, S.C., Siemers, E., Hodes, M.E., Conneally, P.M., Christian, J.C., & Foroud, T. (2000). Subtle changes among presymptomatic carriers of the Huntington's disease gene. Journal of Neurology Neurosurgery and Psychiatry, 69, 773779.
Kirkwood, S.C., Siemers, E., Stout, J.C., Hodes, M.E., Conneally, P.M., Christian, J.C., & Foroud, T. (1999). Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Archives of Neurology, 56, 563568.
Laforet, G.A., Sapp, E., Chase, K., McIntyre, C., Boyce, F.M., Campbell, M., Cadigan, B.A., Warzecki, L., Tagle, D.A., Reddy, P.H., Cepeda, C., Calvert, C.R., Jokel, E.S., Klapstein, G.J., Ariano, M.A., Levine, M.S., DiFiglia, M., & Aronin, N. (2001). Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. Journal of Neuroscience, 21, 91129123.
Langbehn, D.R., Brinkman, R.R., Falush, D., Paulsen, J.S., & Hayden, M.R. (2004). A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clincal Genetics, 65, 267277.
Lawrence, A.D., Hodges, J.R., Rosser, A.E., Kershaw, A., Ffrench-Constant, C., Rubinsztein, D.C., Robbins, T.W., & Sahakian, B.J. (1998). Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain, 121 (Pt 7), 13291341.
Li, S.C., Lindenberger, U., & Sikstrom, S. (2001). Aging cognition: From neuromodulation to representation. Trends in Cognitive Science, 5, 479486.
O'Boyle, D.J., Freeman, J.S., & Cody, F.W. (1996). The accuracy and precision of timing of self-paced, repetitive movements in subjects with Parkinson's disease. Brain, 119 (Pt 1), 5170.
Oldfield, R.C. (1971). The assessment and analysis of handedness: The Edinburgh Inventory. Neuropsychologia, 9, 97113.
Paulsen, J.S., Hayden, M., Stout, J.C., Langbehn, D.R., Aylward, E., Ross, C.A., Guttman, M., Nance, M., Kieburtz, K., Oakes, D., Shoulson, I., Kayson, E., Johnson, S.C., Penziner, E., & The Predict Investigators of the HSG (2006a). Preparing for preventive clinical trials: The Predict HD study. Archives in Neurology, 63, 883890.
Paulsen, J.S., Hoth, K.F., Nehl, C., & Stierman, L. (2005). Critical periods of suicide risk in Huntington's disease. American Journal of Psychiatry, 162, 725731.
Paulsen, J.S., Magnotta, V.A., Mikos, A.E., Paulson, H.L., Penziner, E., Andreasen, N.C., & Nopoulos, P.C. (2006b). Brain structure in preclinical Huntington's disease. Biological Psychiatry, 59, 5763.
Paulsen, J.S., Zhao, H., Stout, J.C., Brinkman, R.R., Guttman, M., Ross, C.A., Como, P., Manning, C., Hayden, M.R., & Shoulson, I. (2001). Clinical markers of early disease in persons near onset of Huntington's disease. Neurology, 57, 658662.
Paulsen, J.S., Zimbelman, J.L., Hinton, S.C., Langbehn, D.R., Leveroni, C.L., Benjamin, M.L., Reynolds, N.C., Jr., & Rao, S.M. (2004). An fMRI Biomarker of Early Neuronal Dysfunction in Presymptomatic Huntington's Disease. American Journal of Neuroradiation, 25, 17151721.
Rajah, M.N. & D'Esposito, M. (2005). Region-specific changes in prefrontal function with age: A review of PET and fMRI studies on working and episodic memory. Brain, 128, 19641983.
Rao, S.M., Harrington, D.L., Haaland, K.Y., Bobholz, J.A., Cox, R.W., & Binder, J.R. (1997). Distributed neural systems underlying the timing of movements. Journal of Neuroscience, 17, 55285535.
Rao, S.M., Mayer, A.R., & Harrington, D.L. (2001). The evolution of brain activation during temporal processing. National Neuroscience, 4, 317323.
Reading, S.A., Dziorny, A.C., Peroutka, L.A., Schreiber, M., Gourley, L.M., Yallapragada, V., Rosenblatt, A., Margolis, R.L., Pekar, J.J., Pearlson, G.D., Aylward, E., Brandt, J., Bassett, S.S., & Ross, C.A. (2004). Functional brain changes in presymptomatic Huntington's disease. Annals of Neurology, 55, 879883.
Reynolds, N.C.Jr., Hellman, R.S., Tikofsky, R.S., Prost, R.W., Mark, L.P., Elejalde, B.R., Lebel, R., Hamsher, K.S., Swanson, S., & Benezra, E.E. (2002). Single photon emission computerized tomography (SPECT) in detecting neurodegeneration in Huntington's disease. Nuclear Medicine Communications, 23, 1318.
Roos, R.A., Vegter-van der Vlis, M., Hermans, J., Elshove, H.M., Moll, A.C., van de Kamp, J.J., & Bruyn, G.W. (1991). Age at onset in Huntington's disease: effect of line of inheritance and patient's sex. Journal of Medical Genetics, 28, 515519.
Rosas, H.D., Hevelone, N.D., Zaleta, A.K., Greve, D.N., Salat, D.H., & Fischl, B. (2005). Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology, 65, 745747.
Talairach, J. & Tournoux, P. (1988). Co-planar Stereotaxic Atlas of the Human Brain. New York: Thieme.
The Huntington's Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell, 72, 971983.
Thieben, M.J., Duggins, A.J., Good, C.D., Gomes, L., Mahant, N., Richards, F., McCusker, E., & Frackowiak, R.S. (2002). The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain, 125, 18151828.
Tobin, A.J. & Signer, E.R. (2000). Huntington's disease: The challenge for cell biologists. Trends in Cell Biology, 10, 531536.
Weeks, R.A., Ceballos-Baumann, A., Piccini, P., Boecker, H., Harding, A.E., & Brooks, D.J. (1997). Cortical control of movement in Huntington's disease. A PET activation study. Brain, 120 (Pt 9), 15691578.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed